DocGo Inc. (DCGO) vs Metagenomi, Inc. Common Stock (MGX)
A side-by-side comparison of DocGo Inc. and Metagenomi, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DCGO
DocGo Inc.
$0.36HealthcareDelayed quote: Oct 6, 2026, 3:09 PM EDT
MGX
Metagenomi, Inc. Common Stock
$1.04HealthcareDelayed quote: Oct 6, 2026, 3:04 PM EDT
Total return — DCGO vs MGX
growth of $100 · dividends reinvested · last 3yDCGO -89.7% (-53.1%/yr)MGX -89.9% (-53.4%/yr)DCGO compounded faster over this window
DCGO MGX
DCGO vs MGX: by the numbers
- •MGX is the larger company ($39M vs $35M market cap).
- •Both run net losses; DCGO's is the smaller (-65.29% vs -689.20% net margin).
Metrics side by side
Valuation
| Metric | DCGO | MGX |
|---|---|---|
| P/S ratio | 0.12 | 2.89 |
| P/B ratio | 0.30 | 0.35 |
Profitability
| Metric | DCGO | MGX |
|---|---|---|
| Gross margin | 30.12% | 74.29% |
| Operating margin | -27.67% | -380.85% |
| Net margin | -65.29% | -689.20% |
| ROE | -161.63% | -83.03% |
| ROIC | -89.44% | -66.03% |
Growth (annualized)
| Metric | DCGO | MGX |
|---|---|---|
| Revenue CAGR (5Y) | 11.63% | N/A |
| Total return CAGR (5Y) | -48.40% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.